Rectal bleeding on Mounjaro: what the evidence says and when to act

What the Mounjaro trial data and prescribing information actually record

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed more than 2,500 adults taking tirzepatide over 72 weeks and recorded adverse events in detail. Rectal bleeding does not appear in the common or uncommon side-effect categories. The side effects reported most often were gastrointestinal: nausea, diarrhoea, vomiting, constipation, and indigestion. The NHS medicines page for tirzepatide reflects the same picture, the GI effects listed are those of altered gut motility and delayed gastric emptying, not bleeding. That does not mean bleeding is impossible in someone taking Mounjaro; it means the medicine is not the direct cause in the way that, say, aspirin or ibuprofen can be.

What Mounjaro does do is slow the movement of food and waste through your digestive system. For some people, particularly in the early weeks of treatment or after a dose increase, this leads to constipation significant enough to cause straining. Straining is a textbook cause of haemorrhoids and small anal fissures, both of which produce the kind of bright-red blood you might notice on tissue paper or in the pan. This is an indirect pathway, the medicine changes gut behaviour, gut behaviour changes bowel habits, and changed bowel habits create a condition that bleeds. Recognising the chain helps explain why this symptom clusters in the first months of treatment without appearing on any official side-effect list.

Causes that need to be ruled out, not assumed away

Bright red blood seen only on the tissue after straining is usually minor and often haemorrhoidal. But rectal bleeding has a wide differential, and some causes are serious. Dark or tarry stools suggest bleeding higher up in the gut. Blood mixed visibly into the stool (rather than coating it) can indicate a colonic source. Bleeding accompanied by a change in bowel habit lasting more than three weeks, unintentional weight loss, or abdominal pain is the pattern GPs are trained to act on quickly, and rightly so.

There is also a gallbladder consideration specific to GLP-1 medicines. Gallbladder problems, including gallstones and gallbladder inflammation, are listed as infrequent side effects in the Mounjaro prescribing information. Gallbladder pain typically presents in the upper abdomen, but referred symptoms can be confusing, and someone with gallbladder disease may also develop digestive upset that they notice lower in the gut. It is worth knowing that the wider evidence on bleeding linked to Mounjaro covers several distinct mechanisms, not just one. A one-minute habit that takes no equipment: check the colour and consistency each time this occurs and note it down, bright red on paper versus dark colour in the water tells a clinician something immediately useful. That note could save a lot of back-and-forth at your appointment.

Anyone who notices rectal bleeding should mention it to their GP or the prescribing clinical team, not wait for the next routine review. If the bleeding is heavy, accompanied by dizziness, or does not settle within a day or two, seek same-day assessment.

Whether a change in periods or other hormonal bleeding is involved

Some women contact their clinical team describing what they think is rectal bleeding and later realise it is menstrual or gynaecological. This is worth separating out clearly. Mounjaro can affect menstrual cycles in some women, particularly those with conditions such as PCOS, because significant weight change alters hormone levels. If you are unsure of the source of bleeding, note when in your cycle it occurs and whether it feels anatomically distinct. There is a separate question around how Mounjaro affects menstrual bleeding that is worth reading if this applies to you, and women taking HRT alongside tirzepatide may also want to look at how Mounjaro interacts with HRT-related bleeding patterns. These are clinically distinct scenarios from rectal bleeding, but they can be confused.

Talking to your clinical team, and what to expect

Mounjaro is a prescription-only medicine; a prescriber reviews your case before each supply. If you are experiencing rectal bleeding at any point during treatment, raise it directly rather than adjusting your dose or stopping without advice. Stopping abruptly is unlikely to be harmful but does mean losing the benefits of treatment unnecessarily if the cause turns out to be unrelated. Your clinical team can help you decide whether to continue, pause, or refer for further investigation.

If you are considering starting tirzepatide and want to understand the full side-effect picture before you do, our tirzepatide overview covers the licensed evidence in detail. You can also explore how Mounjaro works as a weight-loss treatment and review the broader question of whether Mounjaro can cause bleeding of any kind. For those who want to understand what treatment through a regulated UK pharmacy looks like, our consultation page is the place to start, every prescription follows a same-day clinical review by a real, named prescriber. Patients sourcing or researching this medicine from abroad can also find out more about tirzepatide w Polsce, including how availability and regulation differ from the UK.